A 1-Day Training Course Delivered By
Nick Proctor

Dr. Nick Proctor

  • Senior consultant to the pharmaceutical industry for over 20 years, most recently as a Director with Access Infinity. Over the past 15 years, he has led pricing, reimbursement and access projects for the majority of the world’s top pharmaceutical brands and manufacturers.
  • Nick has a strong background in pricing, evidence synthesis, health economics and outcomes research, as well as experience of working with payers in all major developed and emerging international health markets.

Learn

  1. What market access means to the pharmaceutical industry and how to differentiate the different categories of payers.
  2. The patterns of healthcare and pricing & reimbursement systems and the different payer archetypes across Europe.
  3. Understand payers in Europe: Their drivers, their perspectives and decision-making processes.
  4. The market access plan and process, from before phase II up to launch, including strategies and tactics.
  5. Different types of Managed Entry Agreements that are used by payers and pharma to mitigate risk.
  6. How internal stakeholders (e.g. Medical Affairs, Clinical, Marketing, Health Outcomes…) should contribute for optimal results.

Additional Benefits

  • Receive clear schematic overviews of the market access systems in Europe’s major markets as a resource to reference in your daily work.
  • Dr. Nick Proctor is available for Q&A during breaks and after the course so you can discuss challenges you are facing and get advice from a sought-after market access expert.

 

Why You Should Attend

The Content: Throughout the industry, optimising market access is often viewed as a responsibility of the market access departments alone, while in fact the optimal outcome will depend on a cross-functional effort as of phase II. That is why it is absolutely necessary that internal stakeholders in non-market access functions grasp the fundamentals and understand how their function, and in particular their decisions related to pharmaceutical compounds and brands, impact on payer decision making.

The Expert: Nick Proctor is passionate about instilling actionable payer understanding throughout the industry, so expect a true expert who will try to make you think from a payer’s perspective and get you to “see” the patterns in Europe’s complex landscape. Nick has advised multiple companies on market access and pricing strategies at global and local levels.

The Understanding Pharma Market Access & Payers in Europe course is the only available public training course delivered by Nick Proctor on the topic of market access.

Agenda of the Understanding Pharma Market Access & Payers in Europe course

Important: all hours are noted in CET/Brussels Time, so carefully convert into your local time zone!

Short breaks will be offered throughout the day.
 

09:30

Welcome & Introductions (~30 min)

 

Demystifying Market Access (~1 h)

 

  • What do we mean by market access? What does it encompass?
  • Why and how did market access evolve?
  • What are concerns of market access decision makers?

 

Understanding Payer Archetypes (~2 h)

 

  • What are the useful ways of thinking about different types of payers?
  • The 3 universal drivers of payer value
  • The 3 approaches to archetyping payers, illustrated by examples in Europe
  • The strengths and weaknesses of different payer archetype approaches
  • How to decide which approach to use in a particular situation
  • The common missteps and challenges when applying payer archetypes
  • How to successfully use payer archetypes to plan evidence development
13:00Lunch Break

14:00

France & Germany (~1 h)

 
  • Understanding national payer assessment processes and implications in France and Germany
  • Critical stakeholders in these countries
  • Market access challenges and opportunities in these countries

 

Italy & Spain (~30 min)

 
  • Understanding the multi-tiered health systems in Italy and Spain
  • Critical stakeholders in these countries
  • Market access challenges and opportunities in these countries

 

UK (~30 min)

 
  • Overview of UK’s healthcare system
  • Critical stakeholders
  • NICE’s approach to cost-effectiveness decision-making

 

A Cross-functional Process for Optimal Access (~45 min)

 
  • The market access plan and the process as of phase II
  • Milestones and the critical contributions of internal stakeholders
  • Different types of Managed Entry Agreements illustrated by real-world examples

 

Final Q&A (~15 min)

17:00

Close

>> Click here if you wish to receive the PDF brochure of this course

Learning Methodology

Nick has been on CELforPharma’s faculty, teaching about market access principles since 2015. He is a very passionate trainer, actively engaging participants in discussions, and very experienced in leading interactive sessions. In addition, Nick’s practical experience will be used to illustrate key parts of the theory.

One of the most valuable aspects of attending any CELforPharma course is not only being able to have your specific questions answered by a leading expert, but also having the opportunity to share experiences and have in-depth discussions with your international peers.

infoThe typical audience size of our courses ranges from 6 to 20 (max) participants.

Who Should Attend?

All executives in functions that contribute to market access optimisation, in particular:

  • Medical Affairs
  • Marketing
  • Clinical Development
  • Health Outcomes

Obviously, all in-country market access executives moving to an international role will greatly benefit from participating.

As this course is delivered by Nick Proctor, Director with Access Infinity, a leading pharma consultancy company, executives from other professional service agencies should request approval prior to registering for this course. Please contact Annelies Swaan, Director Business Operations, for more information (aswaan@celforpharma.com, tel +32 (0)2 709 01 42).

 

Past Participants

Below is a non-exhaustive list of past participants who have benefited from attending this course.

 

Job Title

Company

Country

International Lead for Rheumatoid Arthritis - Health Economics and Outcomes ResearchAbbvieUSA
Marketing EMEA, Associate DirectorAlexionSwitzerland
Global Market Access ManagerALKDenmark
Senior Project Manager - Global Value, Access & Policy - Strategic Planning & OperationsAmgenSwitzerland
Commercial Area Manager Asia, Middle East & AfricaAOP OrphanUnited Arab Emirates
Head of Strategy Immunology BeneluxBaxaltaNetherlands
Senior Product Manager OncologyBayer Healthcare PharmaceuticalsGermany
Manager EU Government AffairsBiogenBelgium
Pricing and Health Economics SpecialistBoehringer IngelheimPoland
Director Customer Insight & Analytics EuropeBristol-Myers SquibbFrance
Director Health Care Policy & External Affairs (CEU)CSL BehringGermany
Business Intelligence Manager - EPBUEisaiUnited Kingdom
Market Intelligence AnalystFreseniusFrance
Director Medical Affairs EMEA MSGenzymeUSA
Senior Admin AssistantGileadUnited Kingdom
Head of Market AccessGruenenthalGermany
Director, Global Market AccessJanssenUSA
Global Patient Access Manager - CoE Value & AccessLEO PharmaDenmark
New Product Planning and Payor Strategy ManagerLillySpain
Market Development Manager Diabetes CEEMedtronicSwitzerland
Global Pricing Manager | Global Market Access & Pricing | General Medicine and EndocrinologyMerck GroupGermany
Market Access Early Products ManagerNovartisFrance
Global Product ManagerNovo NordiskSwitzerland
Senior European Brand Manager- Antiinfectives | European Specialty Asset TeamPfizerFrance
International Health Policy LeaderRocheSwitzerland
Legal CounselSanofiFrance
Training ManagerServierFrance
International Marketing LeadShireBelgium
Project Coordinator and Business Intelligence ManagerTakedaSwitzerland
Market Access Lead OncoCare & Womens Health EuropeTevaNetherlands

 

Testimonials

Dates & Locations

Currently this CELforPharma course is planned to only be held live online (hosted in Zoom).​​​​
 

  • 14 December 2021, live online

  • 17 March 2022, live online

  • 29 June 2022, live online

  • 6 October 2022, live online

  • 8 December 2022, live online

Included in the Registration Fee​

  • Access to a small-class (max 20 participants), expert led course in real-time, using an interactive platform for break-out rooms, whiteboard exercises, polling, plenary discussions and chats.
  • Course material, which will be provided to you in both digital format (by email) and in hard copy (by post, so you can make notes during the course).
  • Certificate of attendance signed by the expert and CELforPharma.

 

Group Discounts

Team discounts can be offered to 3 or more delegates from the same company.
Contact Annelies Swaan, Director Business Operations, (aswaan@celforpharma.com) for more details.

 

How to Register

  1. Click the "Register Here" button on this page.
  2. Choose a course date, then fill out your personal details and company / invoicing details.
  3. Choose to pay via bank transfer or by credit card.
  4. Click "Confirm Registration". You will be sent an automatic email confirming your registration followed by a personal email containing an invoice and further payment instructions.

For assistance in registering, raising a PO or invoicing, please do not hesitate to contact Kealeigh Steel.
(email: kealeigh.steel@celforpharma.com or call: +32 2 709 01 45)

 

Transfer & Cancellation Policy

Flexible Transfer

  • If a registrant cannot attend the scheduled course, he/she can avoid any cancellation charge by sending a suitable replacement participant.
  • Alternatively, the registrant can transfer once at no extra cost, until 3 weeks prior to the event, to another course held within one year of the original course date.

Registration Cancellation

  • Less than 14 days prior to the course date: registrant liable to pay the full invoiced registration fee.
  • Between 15 and 30 days prior to the course date: registrant liable to pay 50% of the invoiced registration fee.
  • More than 30 days prior to the course date: registrant liable to pay a cancellation fee of € 450 per registrant.
  • If a registrant postpones his/her participation to a future course, and cancels again, no refund can be claimed for registration fees.

Related Courses